Fast diagnostics Opportunity to position rapid molecular diagnostics as a core value proposition for clinics and hospitals seeking to reduce inappropriate antibiotic use and shorten patient wait times, aligning with ID Genomics focus on delivering results within 45 minutes.

Variant sequencing Recent news on sequencing service for variants presents a potential cross-sell to labs and public health customers needing scalable genotyping and sequencing capabilities, expanding beyond point-of-care guidance.

Antibiotic stewardship Market messaging can emphasize antimicrobial stewardship benefits to payers and providers, highlighting reduction in broad-spectrum antibiotic use and associated cost savings linked to rapid, accurate pathogen-antibiotic matching.

Strategic partnerships Current collaborations with IEH Laboratories and low-cost thermocyclers suggest sales pathways through lab networks and OEM-like partnerships; leverage those connections to expand adoption and distribution.

Small team agility With a lean team and <$1M revenue, there is an opportunity to frame scalable, high-margin deployments, with a focus on rapid onboarding, strong customer support, and pilot programs in clinics transitioning to precision diagnostics.